A short review of current implementations of sentinel lymph node mapping in gynecologic cancers

Altin D., TAŞKIN S., Ortac F.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, cilt.22, sa.3, ss.242-248, 2021 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/jtgga.galenos.2021.2021.0025
  • Dergi Adı: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.242-248
  • Anahtar Kelimeler: Sentinel lymph node, endometrial cancer, cervical cancer, vulvar cancer, ovarian cancer, STAGE ENDOMETRIAL CANCER, SQUAMOUS-CELL CARCINOMA, CERVICAL-CANCER, DIAGNOSTIC-ACCURACY, PROGNOSTIC-FACTORS, FROZEN-SECTION, OVARIAN-CANCER, ONCOLOGY-GROUP, VULVAR CANCER, LYMPHADENECTOMY
  • Ankara Üniversitesi Adresli: Evet

Özet

Lymph node metastasis both increases disease stage and alters adjuvant treatment plans in gynecologic cancers. Since a minority of the patients have nodal metastasis, many patients unnecessarily undergo complete lymphadenectomy and are exposed to the subsequent morbidities. Sentinel lymph node (SLN) mapping is an alternative for evaluation of lymph nodes with lesser side effects. Although it is yet an experimental approach in ovarian cancer, it has been incorporated into guidelines for endometrial, cervical and vulvar cancers. We aimed to summarize the current situation of SLN mapping in gynecologic cancers.